Cargando…
Psychopharmacology at the era of EMEA (European Medicines Agency)
Autores principales: | Pestana, Luis Camara, Gananca, Licinia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991988/ http://dx.doi.org/10.1186/1744-859X-9-S1-S73 |
Ejemplares similares
-
EMEA and Gene Therapy Medicinal Products Development in the European Union
por: Papaluca Amati, Marisa, et al.
Publicado: (2003) -
Cross-cultural psychopharmacology: a review
por: Pi, Edmond H, et al.
Publicado: (2010) -
New patients, new disorders, new drugs and the rise of prescriptions
por: Pestana, Luis Camara
Publicado: (2010) -
The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials
por: Marchetti, S, et al.
Publicado: (2007) -
Anne Richards, Chief Investment Officer, Head of EMEA - CERN & Society Board Meeting
por: Brice, Maximilien
Publicado: (2014)